A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT

NCT00751842 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
331
Enrollment
INDUSTRY
Sponsor class

Stopped Based on other clinical trial results it was unlikely the study would meet the efficacy endpoints

Conditions

Interventions

Sponsor

Diamyd Therapeutics AB